BURLINGTON, Mass.–Eastern Corporate Federal Credit Union said it raised a record $57,000 was raised at its 2023 Invitational Golf Tournament benefitting Credit Unions Kids at Heart.
More than 120 golfers and volunteers gathered at Tedesco Country Club in Marblehead, Mass., for the annual golf tournament. The tournament featured contests, games, and an auction raising funds in support of the charitable organization’s mission and vision.
Credit Unions Kids at Heart is a collaborative charitable organization founded in 1996 by EasCorp and the credit union community. Eascorp said the organization’s mission is to help children lead healthy and happy lives, and the group raises funds for research aimed at the prevention, treatment, and cure of pediatric neurological disorders, including cerebral palsy, pediatric brain cancer, pediatric epilepsy and other seizure disorders, and Moyamoya disease.
Credit Unions Kids at Heart works closely with renowned research investigators and clinical care specialists at Boston Children’s Hospital and Beth Israel Deaconess Medical Center.
“We are grateful to EasCorp’s leadership and to the credit union community for their involvement and philanthropy,” said Jane Melchionda, chairman, Credit Unions Kids at Heart. “Our golfers, who represented many Credit Unions Kids at Heart Participating Credit Unions and Corporate Sponsors, gave generously to the cause. We were also pleased to let our Patient Partner families and our Research Investigators meet the people who support them.”
Credit Unions Kids at Heart is a favorite philanthropic activity of the credit union community in New England and beyond, with more than 50 participating credit unions, corporate sponsors, and other business partners. Since its founding, Credit Unions Kids at Heart has donated over $9 million toward its mission.
“We are proud to support the work of Credit Unions Kids at Heart,” said EasCorp President and CEO Cynthia Nelson. “The funds raised at this year’s golf tournament will go directly and in full to life-saving research. We have witnessed firsthand their advancements—new diagnostic tools and breakthrough treatment protocols that are changing the lives of children and adults worldwide.”